Towards a HIV-1 cure: detection and elimination of the HIV-1 reservoir
Targeting HIV-1 hiding places to eliminate HIV-1
There is no cure for HIV-1 as the virus hides within immune cells and replication resumes from these so-called reservoirs when antiretroviral therapy is stopped. We have formed a very productive partnership with our industrial partners QvQ, DDL, UniQure and First Health Pharmaceuticals to develop novel methods to detect and eliminate the immune cells wherein HIV-1 hides. We have isolated these cells and by analyzing these cells we have been able to develop a very efficient two-pronged therapy that eliminates these HIV-1 reservoirs. This strategy was efficient in significantly decreasing the HIV-1 reservoir in the blood from people living with HIV-1.
Over 39 million people worldwide are infected with HIV-1 and more than 1 million people become infected yearly. Although antiretroviral therapy suppresses HIV-1 infection, it cannot cure HIV-1. The virus hides within immune cells, the so-called HIV-1 reservoirs. These HIV-1 reservoirs are difficult to detect and so far it has not been possible to specifically eliminate these reservoirs in order to cure HIV-1. There is therefore an urgent need for the development of novel methods to identify and eliminate these HIV-1 reservoirs.
Together with our industrial partners we have developed novel methods to detect and isolate the cells wherein HIV-1 hides. We have isolate and analyzed these HIV-1 reservoirs and were able to identify cellular processes that were specifically activated in these HIV-1 reservoirs. Using this information we have developed a two-pronged therapy that activated the hiding HIV-1 in cells and subsequent induced cell-death of the cells with the reactivated HIV-1. This method allowed us to strongly decrease the HIV-1 reservoir cells in the blood from people living with HIV-1. We will further develop this innovative two-pronged therapy into a cure for HIV-1. Moreover, the methods to identify and isolate the HIV-1 reservoir in people with HIV-1 will allow us to monitor success of different HIV-1 cures and also allow further development of innovative therapies to cure HIV-1.
Thus, together with our industry partners, clinicians and the HIV-1 infected community we have made major steps towards an HIV-1 cure and acquired further financial funding to continue the translation of our research to clinical therapies for an HIV-1 cure worldwide.
Andere projecten
In elk PPS-project werken kennisinstellingen, bedrijven en zorgpartijen samen aan een concrete gezondheidsvraag. Bekijk het volledige projectoverzicht.
Bekijk de programma’s
Binnen onze programma’s werken bedrijven, kennisinstellingen en regionale partners samen aan innovaties die bijdragen aan betere gezondheid en zorg.
Bekijk de partnerschappen
Strategische publiek-private partnerschappen (PPP's) zijn meerjarige samenwerkingen tussen bedrijven, kennisinstellingen en andere partijen.






